Independent patient information. Not affiliated with, sponsored or endorsed by Nobel Biocare. Read more
Implant AtlasIndependent guide to Nobel Biocare implants

Implant system · Zygomatic

The NobelZygoma™ implant: anchoring in the cheekbone

When the upper jaw has too little bone

Zygomatic implants are much longer than normal implants and are anchored in the cheekbone (zygoma). They are used when the upper jaw has lost so much bone that regular implants cannot be placed without major grafting.12

Request an assessmentRead the guide
Skull model with long implants in the cheekbone (educational illustration)
In short
  • Lengths from 30 to 60 mm.1
  • Two versions: 0° with a conical connection and 45° with an external hex.1
  • Titanium grade 4 with TiUltra™ surface (2025 clearance).1
  • Nobel Biocare's zygomatic implant history in FDA records goes back to 1997.3

Who is it for?

Zygomatic implants are an option for people with severe bone loss in the upper jaw, often after many years of wearing a denture. They are a specialist surgery, usually under sedation or general anaesthesia.

Consensus / guideline

The ITI consensus report on zygomatic implants found mean long-term zygomatic implant survival of 96.2% over a mean follow-up of 6.3 years, with sinusitis occurring in 14.2% of cases. 2

These pooled figures cover zygomatic implants in general, not one manufacturer's system.

Skull model with zygomatic implants
Educational illustration of zygomatic implants in a skull model. Not a Nobel Biocare product image.

Risks to discuss

  • Sinus problems (sinusitis) are the most commonly reported complication.2
  • Surgery is longer and more complex than standard implant surgery; choose an experienced team.
  • Cleaning under the bridge must be very thorough.
Ask how many zygomatic cases the surgeon performs each year and what the plan is if one implant fails.

Would you like a dentist to assess whether this treatment suits you?

Request an assessment

FDA history

510(k)DecisionDevice name (as filed)
K24383425 Aug 2025NobelZygoma TiUltra Implant system
K1830694 Dec 2018NobelZygoma 0°
K16159814 Mar 2017NobelZygoma 0°
K15209316 Mar 2016NobelZygoma 45°
K0701824 Apr 2007ZYGOMA IMPLANT (IMMEDIATE FUNCTION)
K97049916 Oct 1997BRANEMARK SYSTEM ZYGOMATICUS FIXTURE SYSTEM

6 record(s) from the openFDA 510(k) database, retrieved 28 Sep 2026. A 510(k) clearance means FDA found a device substantially equivalent to one already on the market; it is not a quality ranking.

Clinical review pending. Facts on this page are checked against the sources listed below (regulatory records, manufacturer documents, peer-reviewed research). A named clinician will review it before we call it medically reviewed.
Last updated 28 Sep 2026 · How we review

Sources

  1. Regulatory recordFDA 510(k) K243834 — NobelZygoma TiUltra Implant system — U.S. Food and Drug Administration, 2025-08-25. Accessed 28 Sep 2026.
  2. Consensus / guidelineAl-Nawas B et al. ITI consensus report on zygomatic implants — Int J Implant Dent, 2023. Accessed 28 Sep 2026.
  3. Regulatory recordFDA 510(k) K970499 — Brånemark System Zygomaticus Fixture System — U.S. Food and Drug Administration, 1997-10-16. Accessed 28 Sep 2026.

Educational information only. The choice of implant system depends on your anatomy, restorative plan, bone quality and the clinician's assessment. This website does not recommend a specific implant for you.

Clinical assessment

Find out whether implant treatment suits you

Send a few details and, if you have one, a recent x-ray. A dentist from our clinical partner reviews your case and replies with next steps. Free and without obligation.

Request a clinical assessment

This website does not diagnose. Only an examination by a dentist can confirm a treatment plan.

Dentist explaining a panoramic x-ray to a couple
Request a clinical assessment